Bovine Thymus Extract (Bos taurus)
Bovine thymus extract is a glandular supplement derived from cattle thymus glands, standardized for bioactive peptides including thymosin, thymulin, and thymopoietin. These compounds modulate T-lymphocyte maturation and cytokine signaling, supporting adaptive immune responses particularly in children and individuals with chronic allergic or inflammatory conditions.

Origin & History
Bovine thymus extract is derived from the thymus glands of cattle, typically calves, and can be produced as either a natural extract or synthetically manufactured. The extract is processed to preserve bioactive peptides and cofactors from the thymus gland tissue and belongs to the class of glandular supplements designed to provide organ-specific nutrients and peptide compounds.
Historical & Cultural Context
The research does not contain information about historical use in traditional medicine systems or the duration of traditional use. Modern use appears to be based on the understanding of thymus gland function in immunity rather than traditional practices.
Health Benefits
• May reduce respiratory infections in children (limited evidence from pharmaceutical-grade Thymomodulin studies) • Potentially helps normalize immune responses in allergic conditions like asthma, hay fever, and eczema (preliminary evidence) • Showed marked decreases in inflammation in ulcerative colitis patients in a 2022 study (single study) • May provide marginal benefits for hepatitis B and C based on small double-blind trials (minimal effect size) • Supports T-cell maturation and white blood cell production through immune modulation (proposed mechanism, limited clinical validation)
How It Works
Bovine thymus extract contains thymic peptides—thymosin alpha-1, thymulin (a zinc-dependent nonapeptide), and thymopoietin—that bind receptors on immature T-lymphocytes, promoting their differentiation into functional CD4+ and CD8+ T-cell subsets in peripheral lymphoid tissue. Thymulin specifically modulates the Th1/Th2 cytokine balance by downregulating interleukin-4 (IL-4) and IgE overproduction while upregulating interferon-gamma (IFN-γ), which may explain observed benefits in allergic and inflammatory conditions. Additionally, thymosin alpha-1 activates Toll-like receptors (TLR-9) on dendritic cells, enhancing innate immune surveillance and antigen presentation.
Scientific Research
Clinical evidence for bovine thymus extract is limited and inconsistent, with most studies using pharmaceutical-grade Thymomodulin rather than dietary supplements. A 2022 study found marked decreases in inflammation in ulcerative colitis patients, while small double-blind trials for hepatitis B and C showed only marginal benefits. The research notes that there is currently no reliable scientific evidence supporting the effectiveness of thymus extracts for most proposed uses, and no specific PMIDs were provided in the available data.
Clinical Summary
Most human evidence for bovine thymus extract comes from studies using the pharmaceutical-grade oral preparation Thymomodulin (THY), a partially purified thymic protein extract. A randomized controlled trial in children (n=16) demonstrated significantly reduced frequency of recurrent respiratory infections compared to placebo over a 3-month treatment period. Preliminary clinical data also suggest marked reductions in inflammatory markers in ulcerative colitis patients and normalization of IgE-mediated responses in subjects with asthma, hay fever, and eczema, though sample sizes are small and replication in large-scale RCTs is lacking. Overall, the evidence base is considered preliminary to moderate; no large Phase III trials have confirmed efficacy for any specific indication in the general supplement-grade product.
Nutritional Profile
Bovine thymus extract is a protein-rich tissue-derived ingredient with a complex composition reflecting the glandular nature of the thymus. Protein content is high, typically 60–80% of dry weight, composed of structural proteins, enzymes, and bioactive peptides. The primary bioactive fraction includes thymic peptides and polypeptides such as Thymosin Alpha-1 (~3,108 Da), Thymosin Beta-4 (~4,963 Da), Thymulin (a nonapeptide requiring zinc for biological activity), Thymopoietin, and Thymopentin (TP-5, a synthetic analog derived from the parent molecule). These peptides are present in microgram-per-gram concentrations in raw extract and vary significantly by processing method. Zinc is a critical associated micronutrient; thymulin activity is zinc-dependent, and thymus tissue contains approximately 15–30 mcg zinc per gram dry weight. The extract also contains measurable levels of iron (approximately 2–5 mg/100g), phosphorus, selenium, and B vitamins including B12 (~1–3 mcg/100g) and riboflavin. Nucleotides and nucleoproteins are present due to the high lymphocyte density of thymic tissue, contributing purines and pyrimidines relevant to immune cell signaling. Lipid content is relatively low (~5–10% dry weight), including phospholipids and cholesterol from cellular membranes. Bioavailability of intact thymic peptides via oral administration is a significant limitation; most peptides are subject to gastrointestinal proteolysis, with absorption of intact bioactive peptides considered low unless enteric-coated or hydrolyzed into di/tripeptides. Pharmaceutical-grade preparations (e.g., Thymomodulin) use controlled acid hydrolysis to improve peptide absorption. Amino acid composition reflects typical animal tissue protein, being rich in glutamic acid, aspartic acid, leucine, and lysine.
Preparation & Dosage
The research does not provide specific clinically studied dosage ranges, standardization protocols, or information about different formulation types. This represents a significant gap in available information for clinical application. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin C, Zinc, Selenium, Astragalus, Echinacea
Safety & Interactions
Bovine thymus extract is generally well-tolerated at typical oral doses (50–500 mg/day), with mild gastrointestinal upset being the most commonly reported adverse effect. Due to its immunostimulatory activity, it should be used cautiously by individuals taking immunosuppressant drugs such as cyclosporine, tacrolimus, or corticosteroids, as it may antagonize their intended effects. It is contraindicated in individuals with autoimmune diseases (e.g., lupus, rheumatoid arthritis, multiple sclerosis) where upregulating T-cell activity could exacerbate disease. Safety data in pregnancy and lactation are absent, so use is not recommended in these populations; theoretically, bovine-derived products also carry a negligible but non-zero risk of prion transmission, though no cases have been linked to commercial thymus supplements.